Laaser - HIV/AIDS

LAASER at the International AIDS Conference Vienna

The XVIII International Conference took place from 18-23 July in Vienna. All partners of the LAASER program were present at the conference while organising a number of activities. International Civil ...

Interview with pediatric counselor Yvonne Mwelwa Nsabika-Chipasha

“Isolation puts children more at risk: our attitude and behavior can change that in the future.” Yvonne is a pediatric counselor and nurse at Kara Clinic in Lusaka, Zambia. Kara Clinic is ...

"First-line Forever" In the Philippines, Stopping Drug Resistance Before It Starts

July 2010 - Approximately 950 people are on antiretroviral therapy (ART) in the Philippines, and Dr. Rossana Ditangco knows them all. As head of the AIDS Research Group at the Research Institute for T...

LAASER program after 2010

The Dutch Ministry of Foreign Affairs has rejected our application for funding for the LAASER program for 2011 – 2015. Unfortunately, this means that much of our work cannot be continued and new...

HIV drug resistance is inevitable. It is going to happen

Interview with Dr Annette Sohn director of the TREAT Asia network on HIV drug resistance in Asia. (source: www.pharmaccess.org)

‘The bottom line is that Asia is number two globally in ...

When Children Grow Up With HIV - Setting an Adolescent HIV Research Agenda

More than 150,000 children are living with HIV in the Asia-Pacific region, and almost all have had the virus since infancy. With access to antiretroviral therapy (ART) and social support, these childr...

Turning the tide against AIDS in India - an interview with Richard Gere

Richard Gere is recognized internationally for his award-winning work as a film actor and social activist. For more than 25 years, he has been deeply involved in global humanitarian issues, and is esp...

The initiation of MARCH: 'Monitoring Antiretroviral Resistance in Children'

In January 2010, the ‘Monitoring Antiretroviral Resistance in Children’ (MARCH) study was initiated in Uganda. Three clinical sites that also participate in PASER started this new study am...

ART-A and PASER are among the best things in the HIV arena in Africa

interview with Dr Theresa Rossouw on the problem of HIV drugs resistance in South Africa

‘My guess is that already around 5-10 percent of newly reporting HIV patients are resistant to the drugs...

Annual report 2009

The LAASER network is still expanding, with 28 clinical sites in 11 countries building capacity to investigate and address HIV drug resistance in Africa and Asia. Within the network, 127 nur...

LAASER program update, January 2010

With 28 clinical sites in 11 countries, the LAASER network is still expanding, building capacity to investigate and address HIV drug resistance in Africa and Asia. Up to now, a total of 4300 patients ...

Adherence in resource-limited settings

Experiences from two PASER counselors Last month’s UNAIDS report showed that now four million HIV-infected people in low- and middle income countries are receiving the life saving antiretroviral...

PASER-M enrolment completed

We are very proud to announce that the enrolment of PASER-M is complete. On September 28, 2009, the last patient was recruited at Newlands Clinic in Zimbabwe (ZI/CON), which results in a total of 3013...

TREAT Asia and PharmAccess Network meetings

The 9th TREAT Asia Annual Network Meeting was held from 9–13 October 2009 in Bangkok, Thailand. More than 160 participants from 21 countries around the globe participated in the meeting, represe...

LAASER Workplan 2010

In 2010, the LAASER program will enter its last year of implementation. In the past year, all partners worked hard to catch up with the initial delays. The increasing number of patients will generate ...

AIDS Research Information for Asia

TREAT Asia offers a series of topical publications that highlight and summarize recent research of particular interest to the HIV/AIDS community in Asia. The goal of these articles is to present advan...

Pulling Together to combat Treatment Failure

This article originates from the TREAT Asia Report of October 2009

Treatment failure among people living with HIV in Asia is associated with a variety of factors, including a lack of clear, up-to-dat...

LAASER program update

In the first half year of 2009, all partners worked hard to catch up with the initial delays. Both PASER-M and TASER-M exceeded the enrolment targets. In the monitoring studies, a total of 4000 patien...

Capacity building of young clinicians in Asia

This article about investing in the future of HIV Research through capacity building originates from the TREAT Asia Report of July 2009.

In some ways, the challenge of fighting HIV/AIDS in Asia ...

AIDS in Asia: The View From the Global Fund

In the TREAT Asia Report of July 2009 you can find an interview with Dr. Michel Kazatchkine who is a physician and global health expert who has treated people with HIV/AIDS for more than 20 years...